Byetta News
Most Popular Byetta Story
FDA delays Amylin's Byetta LAR
Amylin, Eli Lilly and Alkermes have received an FDA complete response letter for Bydureon, but the companies note in an announcement that there are no requests for new pre-clinical or clinical Read more...
Latest Headlines
- April 12, 2010
- March 15, 2010
- March 10, 2010
- January 27, 2010
- April 1, 2009
- November 10, 2008
- October 17, 2008
- March 4, 2008
- January 4, 2008
- October 17, 2007
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline
